Adage Capital Partners Gp, L.L.C. Merck & Co., Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,425,186 shares of MRK stock, worth $125 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
1,425,186
Previous 2,026,500
29.67%
Holding current value
$125 Million
Previous $182 Million
37.98%
% of portfolio
0.2%
Previous 0.35%
Shares
32 transactions
Others Institutions Holding MRK
# of Institutions
3,842Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$22.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$10.4 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.73 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$5.16 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $222B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...